为您找到"
BT-113
"相关结果约100,000,000个
BT - Records of the Board of Trade and of successor and related bodies Division within BT - Records of the Registrar General of Shipping and Seamen and successor
The register of seamen's tickets (BT 113) covers the years 1845-1854 and is indexed in the alphabetical register (BT 114). These records give the seaman's name, birth place and date, physical characteristics, age when ticketed, previous experience and service record for 1845-1854.
the register of seamen series I in BT 120 (1835-1836) the register of seamen series II, in BT 112 (with its associate name index in BT 119) (1835-1844) the register of seamen's tickets, in BT 113 (the surname index is in BT 114) (1845-1854) the register of seamen series III, in BT 116 (1853-1857)
BIGTREE에서 제공되는 짜릿하고 새로운 1000여 종류에 실시간 스포츠, 라이브 카지노, 슬롯, 미니게임 등 색다르고 완벽한 서비스를 경험해보세요.
INFORMATION ON SERIES OF DOCUMENTS Information on series of documents
Buy Aisin BT-113 Clutch Sets: Complete Clutch Sets - Amazon.com FREE DELIVERY possible on eligible purchases
It is divided into the actual tickets (BT 112) which is arranged in numerical order and the index to the tickets (BT 119). It continues from 1845 to 1854 with tickets (BT 113) and an alphabetical register (BT 114).
BT-113: a CDK7 inhibitors Drug, Initially developed by Brilliant Pharmaceutical Co. Ltd., Now, its global highest R&D status is Preclinical, Mechanism: CDK7 inhibitors (Cyclin-dependent kinase 7 inhibitors), Therapeutic Areas: Neoplasms, Active Indication: Solid tumor, Active Org.: Brilliant Pharmaceutical Co. Ltd..
BT-113 - Releaser manufactured by AISIN applicable for the TOYOTA. This releaser is fully compatible with original part numbers 31230-60270, 31230-60220, and 31230-60221. Order AISIN releaser online and find many other parts and accessories that fit your car, bike or truck.
BT-113: 一种CDK7抑制剂药物，由Brilliant Pharmaceutical Co. Ltd. (成都倍特药业股份有限公司)公司最早进行研发，目前全球最高研发状态为临床前，作用机制: CDK7抑制剂(细胞周期蛋白依赖性激酶7抑制剂)，治疗领域: 肿瘤，在研适应症: 实体瘤，在研机构: 成都倍特药业股份有限公司。